Compare MXE & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MXE | LNSR |
|---|---|---|
| Founded | 1990 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.9M | 69.1M |
| IPO Year | 1994 | 2005 |
| Metric | MXE | LNSR |
|---|---|---|
| Price | $13.25 | $6.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 3.0K | ★ 109.7K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 2.66% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $10.21 | $5.06 |
| 52 Week High | $14.30 | $13.43 |
| Indicator | MXE | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 49.89 | 61.08 |
| Support Level | $12.66 | $5.33 |
| Resistance Level | $13.93 | $12.74 |
| Average True Range (ATR) | 0.22 | 0.37 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 61.79 | 92.13 |
Mexico Equity and Income Fund Inc. is a closed-end, non-diversified management investment company that aims for long-term capital appreciation and current income. It prominently invests in equity, convertible securities, and debt issued by Mexican companies, operating across various sectors. The fund benchmarks its performance against the Mexbol and MSCI Mexico Index. The company provides a vehicle to investors who wish to invest in Mexican companies through a managed non-diversified portfolio as part of their overall investment program.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.